SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) has been assigned a consensus rating of “Buy” from the seven brokerages that are covering the stock, Marketbeat reports. Five analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is […]
Impax Asset Management Group plc raised its position in SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) by 20.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,200,343 shares of the company’s stock after acquiring an additional 205,000 shares during the quarter. Impax Asset […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) Director Jeffrey W. Dunn sold 272,753 shares of SI-BONE stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $22.00, for a total value of $6,000,566.00. Following the completion of the transaction, the director now owns 85,166 shares in the company, valued […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) shot up 3.6% on Tuesday . The company traded as high as $22.31 and last traded at $22.31. 16,169 shares were traded during mid-day trading, a decline of 93% from the average session volume of 241,375 shares. The stock had previously closed at $21.53. Analysts Set New Price Targets […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) rose 3.7% on Wednesday . The stock traded as high as $21.24 and last traded at $21.15. Approximately 58,287 shares traded hands during mid-day trading, a decline of 76% from the average daily volume of 244,169 shares. The stock had previously closed at $20.39. Analyst Upgrades and Downgrades SIBN […]